Most new “small molecules” can be taken by mouth. Many work by blocking pathways that the cancer cells have pirated and become addicted to such as signaling pathways. Examples include ibrutinib, acalabrutinib, duvelisib and others. Others, such as venetoclax, remove blockades that the cancer has created which prevent natural cell death. These therapies target the cancer and spare most healthy cells.
ARTICLES ON TARGETED THERAPIES
When appropriate, the CLL Society will be posting updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.